NCT07149571View on ClinicalTrials.gov

To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 1, 2032

Study Completion Date

December 31, 2032

Conditions

Nonalcoholic Fatty Liver DiseaseMetabolic-associated Fatty Liver Disease

Trial Locations (1)

Unknown

RECRUITING

Tongji hospital, Wuhan

All Listed Sponsors

lead

Tongji Hospital

OTHER

NCT07149571 - To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease | Biotech Hunter | Biotech Hunter